Dear Friends and Global Partners,

We are grateful to all of you for your confidence in our capabilities and your willingness to go the distance to help us realize our vision for SBC as the leading specialty CRO in China. We could not have come this far without you, and we are counting on your support as we secure the private and public financing that will ensure the exponential expansion of our R&D services in 2008.

We are so pleased to share some highlights of SBC’s R&D Services with you.

It’s official: We are now ShanghaiBio Corp, and our name encompasses all of our quality preclinical and clinical support services in China and our U.S. business development /customer support services based in New Jersey. You can find us on the web at our new address: www.shanghaibio.com.

Preferred Partner:  SBC is bridging the gap between western know-how and eastern high-tech, low-cost biophrama services. Our well-trained scientists, state-of-the-art laboratories and established reputation for reliability have earned the trust of the world’s leading pharmaceutical companies. Our pharma/biotech partners, which include most of the top ten global leaders, rely on our expertise and depend upon our ability to speed the search for global R & D solutions.

Sr. Staff Appointments: We have recently hired several professionals from top US research institutions, whose talents and experience will enhance our scientific, management, and communications capabilities.

Scientific Advisory Board: Ten high-level phama executives and distinguished life science professors from leading American universities have agreed to serve as advisors to ShanghaiBio.

Read what the media says about us:

The Next Chinese Outsourcing Wave: Drug Development in Investor’s Business Daily

Eyeing Reward Era for Array-Based Pharma !R&D Services, ShanghaiBio Preps for US IPO in BioArray

From our family to yours, warmest wishes a happy and healthy holiday season                                 and prosperous New Year of 2008 !